Effect of Pitavastatin on high density lipoprotein cholesterol levels in hyperlipidemia.
Not Applicable
- Conditions
- Hyperlipidemia with HDL-C <50mg/d
- Registration Number
- JPRN-UMIN000013384
- Lead Sponsor
- Kanazawa Medical University Diabetology and Endocrinology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients corresponding to the contraindication of pitavastatin 1)Known hypersensitivity to product components 2)Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels(Severe liver damage: AST, ALT >=500IU/L) 3)Co-administration with cyclosporine. 4)Pregnant women, patients who may become pregnant, or nursing mothers 2.Patients who wish to become pregnant 3.Patients who are considerd unsuitable for inclusion by the attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in HDL-C
- Secondary Outcome Measures
Name Time Method Changes in lipid profile (TC, TG, LDL-C, non HDL-C). Investigation of factors associated with Changes in HDL-C.